Quick Answer
enVVeno Medical Corp reported Cash and Equivalents of $3.06 million for fiscal year 2025.
enVVeno Medical Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $3.06M | +74.7% |
| 2024 | $1.75M | -51.5% |
| 2023 | $3.62M | -20.5% |
| 2022 | $4.55M | -91.7% |
| 2021 | $54.73M | +486.3% |
| 2020 | $9.33M | +614.1% |
| 2019 | $1.31M | -52.3% |
| 2018 | $2.74M | +3427.8% |
| 2017 | $77.7K | +37.5% |
| 2016 | $56.5K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.54M | -91.4% | -24.5% |
| June 30, 2025 | $2.04M | -14.1% | -30.4% |
| March 31, 2025 | $2.94M | +26.9% | +67.4% |
| December 31, 2024 | $1.75M | -51.5% | -90.2% |
| September 30, 2024 | $17.91M | +262.2% | +652.7% |
| June 30, 2024 | $2.38M | -49.5% | +2.9% |
| March 31, 2024 | $2.31M | +1.8% | -36.1% |
| December 31, 2023 | $3.62M | -20.5% | -26.8% |
- enVVeno Medical Corp showed an increase of +74.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2016–2025 period, enVVeno Medical Corp’s cash and equivalents has grown by 5323.4% (from $56.5 thousand to $3.06 million).
- The most recent figure is from enVVeno Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: